High prevalence of cancer and other target conditions, insurance access, and expanded support for gene therapy research are driving the demand for the market.
The Global Cell and Gene Therapy Market report assesses the historical and current data along with a thorough analysis of the market dynamics. In the near past, T-cell therapies clinical trials witnessed exponential growth, and constant advances in chimeric antigen receptor T cell therapy are considered as the significant drivers for the growth of the market. Further, while gene therapy has been used mainly for the treatment of cancer, it finds growing use in the treatment of numerous uncommon disease for which there is no treatment at present. Product clearance for non-cancer applications signals a change in customer priorities toward other untapped markets.
To know more about the report @ https://www.emergenresearch.co....m/industry-report/ce